Effect of low-dose aspirin on mortality and viral duration of the hospitalized adults with COVID-19

To clarify the effect of aspirin on mortality and viral duration in adults infected with respiratory syndrome coronavirus 2 (SARS-Cov-2). After propensity score-matched (PSM) case-control analyses 24 pairs of patients were enrolled and followed up for 2 months. Both 30-day and 60-day mortality in th...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Qiang, Huang, Na, Li, Anni, Zhou, Yuanhong, Liang, Liang, Song, Xinyu, Yang, Zhanqiu, Zhou, Xiaolin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886487/
https://www.ncbi.nlm.nih.gov/pubmed/33578548
http://dx.doi.org/10.1097/MD.0000000000024544
_version_ 1783651805238919168
author Liu, Qiang
Huang, Na
Li, Anni
Zhou, Yuanhong
Liang, Liang
Song, Xinyu
Yang, Zhanqiu
Zhou, Xiaolin
author_facet Liu, Qiang
Huang, Na
Li, Anni
Zhou, Yuanhong
Liang, Liang
Song, Xinyu
Yang, Zhanqiu
Zhou, Xiaolin
author_sort Liu, Qiang
collection PubMed
description To clarify the effect of aspirin on mortality and viral duration in adults infected with respiratory syndrome coronavirus 2 (SARS-Cov-2). After propensity score-matched (PSM) case-control analyses 24 pairs of patients were enrolled and followed up for 2 months. Both 30-day and 60-day mortality in the aspirin group were significantly lower than that in the non-aspirin group (P = .021 and P = .030, respectively). The viral duration time between the 2 groups was not significantly different (P = .942). Among adults (with hypertension, cardiovascular diseases) infected with SARS-Cov-2, low-dose aspirin medication (100 mg/day) was associated with lower risk of mortality compared with non-aspirin users.
format Online
Article
Text
id pubmed-7886487
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-78864872021-02-18 Effect of low-dose aspirin on mortality and viral duration of the hospitalized adults with COVID-19 Liu, Qiang Huang, Na Li, Anni Zhou, Yuanhong Liang, Liang Song, Xinyu Yang, Zhanqiu Zhou, Xiaolin Medicine (Baltimore) 4900 To clarify the effect of aspirin on mortality and viral duration in adults infected with respiratory syndrome coronavirus 2 (SARS-Cov-2). After propensity score-matched (PSM) case-control analyses 24 pairs of patients were enrolled and followed up for 2 months. Both 30-day and 60-day mortality in the aspirin group were significantly lower than that in the non-aspirin group (P = .021 and P = .030, respectively). The viral duration time between the 2 groups was not significantly different (P = .942). Among adults (with hypertension, cardiovascular diseases) infected with SARS-Cov-2, low-dose aspirin medication (100 mg/day) was associated with lower risk of mortality compared with non-aspirin users. Lippincott Williams & Wilkins 2021-02-12 /pmc/articles/PMC7886487/ /pubmed/33578548 http://dx.doi.org/10.1097/MD.0000000000024544 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle 4900
Liu, Qiang
Huang, Na
Li, Anni
Zhou, Yuanhong
Liang, Liang
Song, Xinyu
Yang, Zhanqiu
Zhou, Xiaolin
Effect of low-dose aspirin on mortality and viral duration of the hospitalized adults with COVID-19
title Effect of low-dose aspirin on mortality and viral duration of the hospitalized adults with COVID-19
title_full Effect of low-dose aspirin on mortality and viral duration of the hospitalized adults with COVID-19
title_fullStr Effect of low-dose aspirin on mortality and viral duration of the hospitalized adults with COVID-19
title_full_unstemmed Effect of low-dose aspirin on mortality and viral duration of the hospitalized adults with COVID-19
title_short Effect of low-dose aspirin on mortality and viral duration of the hospitalized adults with COVID-19
title_sort effect of low-dose aspirin on mortality and viral duration of the hospitalized adults with covid-19
topic 4900
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7886487/
https://www.ncbi.nlm.nih.gov/pubmed/33578548
http://dx.doi.org/10.1097/MD.0000000000024544
work_keys_str_mv AT liuqiang effectoflowdoseaspirinonmortalityandviraldurationofthehospitalizedadultswithcovid19
AT huangna effectoflowdoseaspirinonmortalityandviraldurationofthehospitalizedadultswithcovid19
AT lianni effectoflowdoseaspirinonmortalityandviraldurationofthehospitalizedadultswithcovid19
AT zhouyuanhong effectoflowdoseaspirinonmortalityandviraldurationofthehospitalizedadultswithcovid19
AT liangliang effectoflowdoseaspirinonmortalityandviraldurationofthehospitalizedadultswithcovid19
AT songxinyu effectoflowdoseaspirinonmortalityandviraldurationofthehospitalizedadultswithcovid19
AT yangzhanqiu effectoflowdoseaspirinonmortalityandviraldurationofthehospitalizedadultswithcovid19
AT zhouxiaolin effectoflowdoseaspirinonmortalityandviraldurationofthehospitalizedadultswithcovid19

Ejemplares similares